|
Therapeutic efficacy and pharmacoeconomics evaulation of pamidronate versus zoledronic acid in multiple myeloma patients |
Qasim S, Saleem U, Ahmad B, Aziz MT, Qadir MI, Mahmood S, Shahzad K |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Qasim S, Saleem U, Ahmad B, Aziz MT, Qadir MI, Mahmood S, Shahzad K. Therapeutic efficacy and pharmacoeconomics evaulation of pamidronate versus zoledronic acid in multiple myeloma patients. Journal of Applied Pharmacy 2011; 3(4): 438-452 Indexing Status Subject indexing assigned by CRD MeSH Bone Density Conservation Agents; Cost-Benefit Analysis; Diphosphonates; Humans; Imidazoles; Multiple Myeloma AccessionNumber 22012015910 Date bibliographic record published 01/08/2012 |
|
|
|